Home » Protea Licenses Cardiovascular Biomarker Tech from Hopkins

Protea Licenses Cardiovascular Biomarker Tech from Hopkins

Jul 21, 2009

NEW YORK (GenomeWeb News) – Protea Biosciences has licensed technology from Johns Hopkins University that it plans to use to develop tools for improving treatment of myocardial ischemia, the company said today.

The company has licensed technology developed in the lab of Hopkins researcher Jennifer Van Eyk that has been used to identify proteins bound to human serum albumin that are associated with cardiovascular disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Apr 30, 2014

Protea Inks Cancer Analysis Alliance with MSKCC, Dana-Farber

May 29, 2014

Protea to Collaborate with U of Southampton on Alzheimer's Markers

Apr 11, 2014

People in the News: Greg Kilby, Erin Seeley

Premium
Jul 09, 2014

Protea, InSphero Collaborate on 3D Technologies for Pharmacokinetics, Toxicity Research

Mar 28, 2014

Cedars-Sinai Creating Research Institute with Proteomics Focus

Jul 31, 2014

Quark Kidney Drug Misses Phase II Endpoint, but Phase III Still On Track

Premium

The Scan

Ancient Wheat

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

'High School Never Ends'

Joel Achenbach explores at National Geographic why people find science difficult to believe.

This Week in Science

In Science this week: gene linked to expansion of the human neocortex, and more.

Bit of an Increase

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Mar
05
Featured Webinar

Integrating Metabolomic and Proteomic Profiles for 'Less Impersonal' Medicine

Sponsored by
SomaLogic

In this live webcast, Robert Gerszten of Massachusetts General Hospital will describe an ongoing project that is integrating metabolic and proteomic profiling to gain a better understanding of cardiometabolic disease.

What's Popular?

In Proteomics & Protein Research

  1. Caprioli Lab Develops Approach to Integrate Imaging Mass Spec, Optical Microscopy Data

    Premium

  2. CPTAC Researchers Examine Development, Feasibility of Highly Multiplexed MRM-MS Assays

  3. MIT Researchers Equip Illumina Sequencer to Measure DNA-Protein Binding

    Premium

  4. Pressure Bio Q2 Revenues Increase 10 Percent

  5. Citing Disappointing Discovery Efforts, Researchers Look to Proteomics' Clinical Future

    Premium

Sponsorships

Privacy Policy.  Copyright © 2015 Genomeweb LLC.  All Rights Reserved.